Baxter International Inc. vs ResMed Inc.
A head-to-head of Baxter International Inc. (BAX) and ResMed Inc. (RMD) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | BAX | RMD |
|---|---|---|
| Market Cap | $11.68B | $28.86B |
| P/E (TTM) | — | 19.19 |
| Forward P/E | 8.50 | 16.86 |
| P/S | 0.79 | 5.39 |
| P/B | 1.93 | 4.46 |
| EV/EBITDA | 8.17 | 13.65 |
| Dividend Yield | 2.29% | 1.17% |
| Profit Margin | -9.70% | 27.44% |
| Gross Margin | 30.05% | 59.36% |
| Operating Margin | 1.57% | 32.79% |
| Revenue Growth (YoY) | +2.90% | +10.81% |
| FCF Yield | 8.04% | 5.81% |
| Debt / Equity | 157.30 | 10.23 |
| Current Ratio | 1.85 | 3.01 |
Which is better: Baxter International Inc. or ResMed Inc.?
- ✓Larger by market cap: ResMed Inc.
- ✓Higher dividend yield: Baxter International Inc.
- ✓More profitable (net margin): ResMed Inc.
- ✓Faster revenue growth: ResMed Inc.
- ✓Higher free-cash-flow yield: Baxter International Inc.
Very close — each leads on 6 metrics.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.